The AHA appreciates the Medicare Payment Advisory Commission’s concerns about rising pharmaceutical costs and urged the Commission to continue to take action to achieve sustainable drug pricing. “Hospitals, and the clinicians who work in them, know firsthand the lifesaving potential of drug therapies … however, an unaffordable drug is not a lifesaving drug,” AHA said in a letter to MedPAC commissioners. AHA shared recommendations with MedPAC, including mandating an average sales price inflation cap for Medicare Part B and Part D drugs, and applying the cap to both high-cost and lower-cost drugs; identifying approaches to preventing excessively high launch prices as a response to an ASP inflation cap; maintaining the ASP plus 6 percent payment methodology for Part B drugs; testing a new Part D payment model that reduces or eliminates reinsurance payments while making appropriate adjustments to the direct subsidy rate; and improving annual public reports on Medicare Part B and Part D drug costs by making them more consumer and provider-friendly.

Related News Articles

Headline
Health care workers who face the complexities of working with big data and population health must remain vigilant to potential public health threats and…
Headline
More than 700 health care leaders came together today in Chicago for the Association for Community Health Improvement's National Conference focused on…
Headline
Rep. Richard Neal, D-Mass., will address the AHA Annual Membership Meeting on April 9 in Washington, D.C. Neal is the chairman of the House Ways and Means…
Headline
During the AHA’s Annual Membership Meeting in Washington, D.C., Michael Rodgers, former senior vice president of the Catholic Health Association of the United…
Blog
The health sector is in midst of historic change—and it’s being driven by new technology and patients’ increasing desire to play a larger role in directing…
Headline
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…